23andMe: a new two-sided data-banking market model

BACKGROUND: Since 2006, the genetic testing company 23andMe has collected biological samples, self-reported information, and consent documents for biobanking and research from more than 1,000,000 individuals (90 % participating in research), through a direct-to-consumer (DTC) online genetic-testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoeklé, Henri-Corto, Mamzer-Bruneel, Marie-France, Vogt, Guillaume, Hervé, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826522/
https://www.ncbi.nlm.nih.gov/pubmed/27059184
http://dx.doi.org/10.1186/s12910-016-0101-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826522/
https://www.ncbi.nlm.nih.gov/pubmed/27059184
http://dx.doi.org/10.1186/s12910-016-0101-9

Ejemplares similares